World-first clinical practice guideline for the appropriate use of psychedelics

The new “Clinical Practice Guideline for the Appropriate Use of Methylenedioxymethamphetamine-assisted psychotherapy (MDMA-AP) for Post-Traumatic Stress Disorder (PTSD)” has been approved by the National Health and Medical Research Council (NHMRC). The Guideline is the world’s first related to MDMA-AP to be developed using the gold standard Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup